Schedule 13G ownership disclosure

Zymeworks Inc

Common Stock, par value $0.00001 per share · CUSIP: 98985Y108

Event date: 2024-12-31

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • Redmile Group, LLC

    Shares: 4,840,463.00 · Class: 7.0%

  • Jeremy C. Green

    Shares: 4,840,463.00 · Class: 7.0%

  • Redmile Biopharma Investments III, L.P.

    Shares: 3,470,727.00 · Class: 5.0%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001104659-25-014387
Form type
SCHEDULE 13G/A
Filer
Redmile Group, LLC
CIK
CIK 1425738
Filed
Feb 14, 2025
Reporting period
Dec 31, 2024
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub